At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
4/day of 4g P-OM3 capsules +2 moredrug
Likely dose
4/day of 4g P-OM3 capsulesfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Omacor: Measures of Endothelial Function and triGlyceride Alteration
In Brief
A clinical study evaluating 4/day of 4g P-OM3 capsules, 4/day of 1g P-OM3 capsules, and 1 other intervention for Hypertriglyceridemia. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the cardiovascular and lipid effects of two doses of an omega-3 fatty acid concentrate in a group of people who normally are not treated for high lipids.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertriglyceridemia
CountriesUnited States
CollaboratorsReliant Pharmaceuticals
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2007
First PostedJul 2007
Primary CompletionJan 2009
TodayJul 2026
First PostedJul 20, 2007
Enrollment StartJul 1, 2007
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 18.9 years ago
Interventions
4/day of 4g P-OM3 capsulesdrug
4/day of 4g P-OM3 capsules for 8 weeks
4/day of 1g P-OM3 capsulesdrug
4/day of 1g P-OM3 capsules for 8 weeks
Corn Oil Placebo, 4 capsules/day for 8 weeksdrug
4 capsules per day of corn oil placebo for 8 weeks